Cargando…

COVID-19-associated liver injury (COVALI): role of hepatologists

Detalles Bibliográficos
Autores principales:	Sumida, Yoshio, Yoneda, Masashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249182/ https://www.ncbi.nlm.nih.gov/pubmed/34212231 http://dx.doi.org/10.1007/s00535-021-01809-9

Ejemplares similares

Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021)

The liver in times of COVID-19: What hepatologists should know
por: Ridruejo, Ezequiel, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen
por: Rodríguez-Morales, Alfonso J., et al.
Publicado: (2020)

What hepatologists need to know about COVID-19?
por: Yapali, Suna
Publicado: (2020)

Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know?
por: Sharma, Praveen, et al.
Publicado: (2021)

Care Pattern for Fontan-Associated Liver Disease by Academic Pediatric Hepatologists in Canada
por: Kehar, Mohit, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
por: Khandelwal, Reshu, et al.
Publicado: (2021)

Advancing health equity: The Association of Black Gastroenterologists and Hepatologists
por: White, Pascale M., et al.
Publicado: (2021)

Liver injury in COVID-19 – The culprit may not be COVID-19!
por: Singh, Aditya, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?
por: Ahmed, Mohamed H., et al.
Publicado: (2012)

Factors influencing the participation of gastroenterologists and hepatologists in clinical research
por: Dev, Anouk T, et al.
Publicado: (2008)

Liver Injury in COVID-19: Caution and Management
por: Cao, Jiasheng, et al.
Publicado: (2020)

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States
por: Murayama, Anju, et al.
Publicado: (2022)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Clinical Characteristics of COVID-19 in Patients With Liver Injury
por: Chen, Peng, et al.
Publicado: (2020)

Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis
por: NG, Alexander
Publicado: (2021)

Herbal Immunity Booster-Associated Liver Injury During COVID-19 Pandemic and Aflatoxins
por: Vamadevaiah, Ravishankar M., et al.
Publicado: (2022)

Moving Toward Impact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists
por: Rogal, Shari S., et al.
Publicado: (2020)

Barriers to research productivity among gastroenterologists and hepatologists in Saudi Arabia
por: AlSardi, Mais, et al.
Publicado: (2020)

COVID-19 Related Liver Injury: Call for International Consensus
por: Ye, Zheng, et al.
Publicado: (2020)

Herbal Immune Booster–Induced Liver Injury in the COVID-19 Pandemic
por: Rastogi, Mukul, et al.
Publicado: (2022)

The Rate of Referral of Hepatitis Virus Carriers to Hepatologists and the Factors Contributing to Referral
por: Takata, Kazuhide, et al.
Publicado: (2017)

International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations
por: Cadranel, Jean-François David, et al.
Publicado: (2023)

A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic
por: Bloom, Patricia P.
Publicado: (2020)

Liver Injury in Severe COVID-19 Disease: Need a Closer Look!
por: Jindal, Ankur
Publicado: (2021)

The Topic of COVID-19–Related Liver Injury Needs More Rigorous Research
por: Lv, Xiu-He, et al.
Publicado: (2020)

Current and future pharmacological therapies for NAFLD/NASH
por: Sumida, Yoshio, et al.
Publicado: (2017)

Glycogen Hepatopathy: An Under-recognized Hepatic Complication of Uncontrolled Type 1 Diabetes Mellitus
por: Sumida, Yoshio, et al.
Publicado: (2017)

Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
por: Rismanbaf, Ali, et al.
Publicado: (2020)

Impact of Liver Injury in COVID-19 Patients: Single-center Retrospective Cohort Analysis
por: Desai, Jiten, et al.
Publicado: (2020)

What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction
por: Kriss, Michael, et al.
Publicado: (2021)

Palliative Care Always: Hepatology—Virtual Primary Palliative Care Training for Hepatologists
por: DeNofrio, Jan C., et al.
Publicado: (2021)

The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making
por: Cucchetti, Alessandro, et al.
Publicado: (2020)

Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19
por: Sato, Ken, et al.
Publicado: (2021)

Diffuse axonal injury associated with COVID-19 infection()
por: Lopez-Fernández, Alba, et al.
Publicado: (2020)

Association of chronic liver disease with the prognosis of COVID-19 patients
por: Long, Junyu, et al.
Publicado: (2022)

NSAID-associated drug-induced liver injury prior to and following liver transplantation
por: Gumussoy, Mesut, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08fnrmtl5s7q94adtss9pfo81r